SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pojak watched as the world played hot potato with CTO shit coins. Now, it's his moment. With Pepe's legendary meme power and Wojak's emotional depth, Pojak brings a new level of influence, wealth, and ethics. Born into meme royalty with luxury and wisdom from Pepe and Wojak, he faced hardship when the original developer rugged the project. The community rose up and took control. Pojak was reborn, stronger and more determined.

Pojak

PJ CRYPTO ($PJ) is trending as community members debate whether it's a buying opportunity or a potential scam. Some investors claim "smart money" is accumulating the token, while others urge caution. The discussion centers on its momentum and potential for future growth within the Solana ecosystem.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media is trending amid discussions around Trump's recent actions, including commuting George Santos' sentence, sparking debate and political commentary. The community is actively discussing the implications of these decisions and their broader impact. Some users are expressing discontent with the current political landscape.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd.

SUGP is trending due to a record hospital contract and regained NASDAQ compliance, sparking discussions about a potential short squeeze. Traders are comparing it to other Hong Kong-based stocks that have recently experienced significant gains, citing its low float and high cost to borrow. The community anticipates a potential breakout soon, with some drawing parallels to other high-flying stocks.

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Resmed Inc.

ResMed ($RMD) is trending amid speculation of a potential acquisition or partnership with Incannex ($IXHL), fueled by positive Phase 2 data for a sleep apnea treatment and a shared advisory board member. The community is discussing the strategic implications of this collaboration, including ResMed's potential to co-opt a competitor and expand its product offerings beyond CPAP machines. Option traders are actively trading calls, anticipating a significant move pending further developments.

Xylem, Inc. engages in the design, manufacture, and application of engineered technologies for the water industry. It operates through the following business segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment focuses on the transportation, treatment and testing of water. The Applied Water segment encompasses the uses of water and focuses on the commercial, residential, and industrial end markets. The Measurement and Control Solutions segment focuses on developing technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The company was founded in 2011 and is headquartered in Washington, DC.

Xylem Inc

XYL is trending as the water technology company garners attention with a series of analyst rating updates and price target revisions. Community discussion also highlights call option activity, with many traders outlining specific strategies with defined entry and exit points. Some investors are also reacting to the company's focus on sustainable solutions and partnerships to tackle global water challenges.

Westinghouse Air Brake Technologies Corp. engages in the provision of equipment, systems, and value-added services for the rail industry. It operates through the Freight and Transit segments. The Freight segment builds new locomotives, manufactures and services components for new and existing freight cars and locomotives, rebuilds freight locomotives, supplies railway electronics, positive train control equipment, and signal design and engineering services, and provides related heat exchange and cooling systems. The Transit segment manufactures and services components for new and existing passenger transit vehicles, including regional trains, high speed trains, subway cars, light-rail vehicles, and buses, builds new commuter locomotives, refurbishes subway cars, and provides heating, ventilation, air conditioning equipment, and doors for buses and subway cars. The company was founded in 1869 and is headquartered in Pittsburgh, PA.

Westinghouse Air Brake Technologies Corp

WAB is trending due to a recent $600 million memorandum with Kazakhstan Temir Zholy for electric shunters and LNG-powered locomotives, highlighting a move towards sustainable rail tech. The community is discussing the company's innovative strides in rail modernization and its potential to reduce emissions. Additionally, positive analyst ratings and increased price targets have spurred interest in WAB's growth prospects.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending following positive preliminary data from its Farnesyl Transferase Inhibitor (FTI) programs presented at the European Society for Medical Oncology (ESMO) Congress, highlighting the potential of FTIs to enhance clinical activity in treating HRAS-mutant solid tumors and HNSCC with PIK3CA alterations; the community is actively discussing potential price targets and catalysts within the next few months, while also noting the company's strong cash position and strategic partnership.

Equifax, Inc. engages in the provision of information solutions and human resources business process outsourcing services. It operates through the following business segments: U.S. Information Solutions, Workforce Solutions and International. The U.S. Information Solutions segment includes consumer and commercial information services, mortgage loan origination information, financial marketing services, and identity management. The Workforce Solutions segment covers employment, income, and social security number verification services as well as complementary payroll-based transaction and employment tax management services. The International segment offers information, technology, and services to support debt collections and recovery management in Canada, Europe, Latin America and Asia Pacific. The company was founded by Cator Woolford and Guy Woolford in 1899 and is headquartered in Atlanta, GA.

Equifax, Inc.

Equifax ($EFX) is trending due to its strategic moves in the credit scoring market, specifically cutting prices to compete with FICO, sparking community discussion around potential pricing wars and margin impacts. Community members are actively discussing the competitive landscape and Equifax's long-term growth strategy amid regulatory shifts. Upgrades from analysts and new product launches are also contributing to the increased attention on the stock.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

BioMarin Pharmaceutical is trending as the community discusses its potential as a buyout candidate, with some analysts projecting significant upside. However, opinions are divided, as some investors express frustration with the stock's performance and cite concerns about competition and pipeline execution. Option activity is high, reflecting both bullish and bearish sentiment.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is trending due to increased call options activity and analyst upgrades, signaling bullish sentiment. The community is discussing its AI potential and the impact of the Juniper Networks acquisition, despite mixed opinions on its recent financial guidance. Some see it as undervalued, while others express concerns about slowing revenue growth and potential overreaction to recent news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Predict a 244.05% Upside in Spyre Therapeutics (SYRE): Here's  What You Should Know

How Much Upside is Left in Spyre Therapeutics (SYRE)? Wall Street Analysts Think 258.34%

Spyre Therapeutics to Participate in Upcoming March Investor Conferences

Spyre Therapeutics to Participate in Upcoming March Investor Conferences Spyre Therapeutics to Participate in Upcoming March Investor Conferences PR Newswire WALTHAM, Mass., Feb. 25, 2025 WALTHAM...

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the...

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Feb. 7, 2025 WALTHAM, Mass., Feb. 7, 2025 /PRNewswire...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spyre Therapeutics, Inc. - SYRE SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts

Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts Spyre Therapeutics Highlights 2025 Priorities and Robust Pipeline of Upcoming Clinical Readouts PR...

Spyre Therapeutics Announces Grants of Inducement Awards Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Jan. 3, 2025 WALTHAM, Mass., Jan. 3, 2025 /PRNewswire...

Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.

Spyre Therapeutics Inc.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$22.40
Prev Close	$22.24
Open	$21.93
Dividend Yield	0.00%
50-Day Moving Average	$16.96
Beta	0.87
Avg. Volume	653,057.90
PE Ratio	-7.37

52-Week High	$40.26
52-Week Low	$10.91
Market Capitalization	$1.36B
EPS (Annual)	-$3.18
Price to Book	2.99
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

SYRE
Aeglea BioTherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SYRE News

SYREAeglea BioTherapeutics Inc